SABS SAB Biotherapeutics

Watchlist

Close Apr 26 16:00 ET

39.21MMarket Cap-556P/E (TTM)

SAB Biotherapeutics Stock Analyst Ratings & Price Target

Updated: Apr 4, 2024

Based on 2 analysts giving stock ratings to SAB Biotherapeutics in the past 3 months

Buy

Updated: Apr 4, 2024

The average SAB Biotherapeutics stock price target is 15.50 with a max estimate of 25.00 and a min estimate of 6.00

Review SAB Biotherapeutics earnings estimates

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Updated: Apr 4, 2024

Buy

Updated: Apr 4, 2024

Overall